• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

    19.12 -0.91 (-4.54%)
    Streaming Delayed Price Updated: 11:48 AM EDT, May 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 66,248
    Open 20.04
    Bid (Size) 19.11 (800)
    Ask (Size) 19.13 (100)
    Prev. Close 20.03
    Today's Range 19.11 - 20.17
    52wk Range 12.56 - 26.30
    Shares Outstanding 54,902,942
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript ↗
    Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript 
    Via The Motley Fool
    News headline image
    PLSE Q4 2025 Earnings Transcript ↗
    PLSE Q4 2025 Earnings Transcript 
    Via The Motley Fool
    Topics Intellectual Property

    Performance

    YTD
    +42.8%
    +42.8%
    1 Month
    -16.9%
    -16.9%
    3 Month
    +39.5%
    +39.5%
    6 Month
    +13.9%
    +13.9%
    1 Year
    +11.2%
    +11.2%

    More News

    Read More
    News headline image
    Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences Inc (NASDAQ:PLSE) Narrows Q4 Loss, Beats Revenue Estimates ↗
    Via Chartmill
    News headline image
    Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
    From Pulse Biosciences
    Via Business Wire
    News headline image
    Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
    From Pulse Biosciences, Inc
    Via Business Wire
    News headline image
    Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
    From Pulse Biosciences, Inc.
    Via Business Wire
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
    From Pulse Biosciences, Inc.
    Via Business Wire
    News headline image
    Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Pulse Biosciences, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Pulse Biosciences, Inc - Common Stock publicly traded?
    Yes, Pulse Biosciences, Inc - Common Stock is publicly traded.
    What exchange does Pulse Biosciences, Inc - Common Stock trade on?
    Pulse Biosciences, Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Pulse Biosciences, Inc - Common Stock?
    The ticker symbol for Pulse Biosciences, Inc - Common Stock is PLSE on the Nasdaq Stock Market
    What is the current price of Pulse Biosciences, Inc - Common Stock?
    The current price of Pulse Biosciences, Inc - Common Stock is 19.12
    When was Pulse Biosciences, Inc - Common Stock last traded?
    The last trade of Pulse Biosciences, Inc - Common Stock was at 05/05/26 11:48 AM ET
    What is the market capitalization of Pulse Biosciences, Inc - Common Stock?
    The market capitalization of Pulse Biosciences, Inc - Common Stock is 1.05B
    How many shares of Pulse Biosciences, Inc - Common Stock are outstanding?
    Pulse Biosciences, Inc - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.